(Q33604204)

28 July 2017

Suicide in the course of the treatment of depression (English)

1 reference

28 July 2017

0 references

D Healy

1

1 reference

28 July 2017

C Langmaak

series ordinal

2

1 reference

28 July 2017

M Savage

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Journal of Psychopharmacology

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

94-99

1 reference

28 July 2017

1

1 reference

28 July 2017

Fluoxetine and suicide

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Depressive disorder in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Fatal toxicity of antidepressant drugs in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Reserpine in the treatment of anxious and depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Conclusiveness of rechallenge in the interpretation of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Suicide Rates in the Lundby Study: Mental Illness as a Risk Factor for Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

The Fluoxetine and Suicide Controversy : A Review of the Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Reflections on controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Use of antidepressants among people committing suicide in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Antidepressants and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Toward the operational identification of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Milnacipran and selective serotonin reuptake inhibitors in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Emergence of intense suicidal preoccupation during fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

Intensive in-patient and community intervention versus routine care after attempted suicide. A randomised controlled intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300110

10.1177/026988119901300110

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference